193 related articles for article (PubMed ID: 22134117)
1. Effect of oleic acid modified polymeric bilayered nanoparticles on percutaneous delivery of spantide II and ketoprofen.
Shah PP; Desai PR; Singh M
J Control Release; 2012 Mar; 158(2):336-45. PubMed ID: 22134117
[TBL] [Abstract][Full Text] [Related]
2. Enhanced skin permeation using polyarginine modified nanostructured lipid carriers.
Shah PP; Desai PR; Channer D; Singh M
J Control Release; 2012 Aug; 161(3):735-45. PubMed ID: 22617521
[TBL] [Abstract][Full Text] [Related]
3. Skin permeating nanogel for the cutaneous co-delivery of two anti-inflammatory drugs.
Shah PP; Desai PR; Patel AR; Singh MS
Biomaterials; 2012 Feb; 33(5):1607-17. PubMed ID: 22118820
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous absorption and anti-inflammatory effect of a substance P receptor antagonist: spantide II.
Babu RJ; Kikwai L; Jaiani LT; Kanikkannan N; Armstrong CA; Ansel JC; Singh M
Pharm Res; 2004 Jan; 21(1):108-13. PubMed ID: 14984264
[TBL] [Abstract][Full Text] [Related]
5. Investigation of follicular and non-follicular pathways for polyarginine and oleic acid-modified nanoparticles.
Desai PR; Shah PP; Hayden P; Singh M
Pharm Res; 2013 Apr; 30(4):1037-1049. PubMed ID: 23187866
[TBL] [Abstract][Full Text] [Related]
6. Topical ketoprofen nanogel: artificial neural network optimization, clustered bootstrap validation, and in vivo activity evaluation based on longitudinal dose response modeling.
Elkomy MH; Elmenshawe SF; Eid HM; Ali AM
Drug Deliv; 2016 Nov; 23(9):3294-3306. PubMed ID: 27066917
[TBL] [Abstract][Full Text] [Related]
7. Enhanced transdermal delivery of ketoprofen from bioadhesive gels.
Singh S; Gajra B; Rawat M; Muthu MS
Pak J Pharm Sci; 2009 Apr; 22(2):193-8. PubMed ID: 19339232
[TBL] [Abstract][Full Text] [Related]
8. PLGA implant tablet of ketoprofen: comparison of in vitro and in vivo releases.
Onishi H; Takahashi M; Machida Y
Biol Pharm Bull; 2005 Oct; 28(10):2011-5. PubMed ID: 16204968
[TBL] [Abstract][Full Text] [Related]
9. Transdermal delivery of ketoprofen: the influence of drug-dioleylphosphatidylcholine interactions.
Garcia MT; da Silva CH; de Oliveira DC; Braga EC; Thomazini JA; Bentley MV
Pharm Res; 2006 Aug; 23(8):1776-85. PubMed ID: 16858649
[TBL] [Abstract][Full Text] [Related]
10. [Effect of enhancers on the permeation of ketoprofen in vitro].
Hu JH; Zhu Y
Yao Xue Xue Bao; 1996; 31(1):48-53. PubMed ID: 8762460
[TBL] [Abstract][Full Text] [Related]
11. Small molecule delivery to solid tumors with chitosan-coated PLGA particles: A lesson learned from comparative imaging.
Park J; Pei Y; Hyun H; Castanares MA; Collins DS; Yeo Y
J Control Release; 2017 Dec; 268():407-415. PubMed ID: 29111150
[TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer.
Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ
Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995
[TBL] [Abstract][Full Text] [Related]
13. Comparison of PLGA and lecithin/chitosan nanoparticles for dermal targeting of betamethasone valerate.
Özcan I; Azizoğlu E; Senyiğit T; Özyazici M; Özer Ö
J Drug Target; 2013 Jul; 21(6):542-50. PubMed ID: 23390922
[TBL] [Abstract][Full Text] [Related]
14. Transdermal iontophoresis of flufenamic acid loaded PLGA nanoparticles.
Malinovskaja-Gomez K; Labouta HI; Schneider M; Hirvonen J; Laaksonen T
Eur J Pharm Sci; 2016 Jun; 89():154-62. PubMed ID: 27131608
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronic acid-grafted PLGA nanoparticles for the sustained delivery of berberine chloride for an efficient suppression of Ehrlich ascites tumors.
Bhatnagar P; Kumari M; Pahuja R; Pant AB; Shukla Y; Kumar P; Gupta KC
Drug Deliv Transl Res; 2018 Jun; 8(3):565-579. PubMed ID: 29441466
[TBL] [Abstract][Full Text] [Related]
16. Improved percutaneous delivery of ketoprofen using combined application of nanocarriers and silicon microneedles.
Vučen SR; Vuleta G; Crean AM; Moore AC; Ignjatović N; Uskoković D
J Pharm Pharmacol; 2013 Oct; 65(10):1451-62. PubMed ID: 24028612
[TBL] [Abstract][Full Text] [Related]
17. Transient aggregation of chitosan-modified poly(d,l-lactic-co-glycolic) acid nanoparticles in the blood stream and improved lung targeting efficiency.
Lee SY; Jung E; Park JH; Park JW; Shim CK; Kim DD; Yoon IS; Cho HJ
J Colloid Interface Sci; 2016 Oct; 480():102-108. PubMed ID: 27421112
[TBL] [Abstract][Full Text] [Related]
18. Intracellular drug delivery by poly(lactic-co-glycolic acid) nanoparticles, revisited.
Xu P; Gullotti E; Tong L; Highley CB; Errabelli DR; Hasan T; Cheng JX; Kohane DS; Yeo Y
Mol Pharm; 2009; 6(1):190-201. PubMed ID: 19035785
[TBL] [Abstract][Full Text] [Related]
19. Transdermal enhancement strategy of ketoprofen and teriflunomide: The effect of enhanced drug-drug intermolecular interaction by permeation enhancer on drug release of compound transdermal patch.
Liu C; Guan Y; Tian Q; Shi X; Fang L
Int J Pharm; 2019 Dec; 572():118800. PubMed ID: 31678378
[TBL] [Abstract][Full Text] [Related]
20. Doxorubicin-loaded poly (lactic-co-glycolic acid) nanoparticles coated with chitosan/alginate by layer by layer technology for antitumor applications.
Chai F; Sun L; He X; Li J; Liu Y; Xiong F; Ge L; Webster TJ; Zheng C
Int J Nanomedicine; 2017; 12():1791-1802. PubMed ID: 28424550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
